Biology

Potential new symptomatic drugs for Alzheimer’s disease

Disease-modifying therapy for dementia: Challenges with early detection at pre-dementia stage

Ethical considerations of biomarker use in prodromal Alzheimer’s disease

The landscape of biomarkers for the management of Alzheimer’s disease

Task force from Geneva: Roadmap for biomarker validation in Alzheimer’s disease

Current approaches for the management of Alzheimer’s disease

Prevention strategies for Alzheimer’s disease

Imaging of Alzheimer’s disease